- Minerva Neurosciences (NASDAQ:NERV) -24% after MIN-117 flunks mid-stage depression study.
- Apogee Enterprises (NASDAQ:APOG) -17% on Q3 earnings.
- Xperi (NASDAQ:XPER) -12% on merger with Tivo.
- Herman Miller (NASDAQ:MLHR) -10% on Q2 earnings.
- Green Dot (NYSE:GDOT) -10% on disappointing outlook.
- Akorn (NASDAQ:AKRX) -5%.